A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
Clinical trial NCT06046495 · RECRUITING
Trial details
- NCT number
- NCT06046495
- Sponsor
- Avistone Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-08
- Primary completion
- 2028-02-09
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.